LU90245A1 - - Google Patents

Info

Publication number
LU90245A1
LU90245A1 LU90245A LU90245A LU90245A1 LU 90245 A1 LU90245 A1 LU 90245A1 LU 90245 A LU90245 A LU 90245A LU 90245 A LU90245 A LU 90245A LU 90245 A1 LU90245 A1 LU 90245A1
Authority
LU
Luxembourg
Application number
LU90245A
Other versions
LU90245B1 (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25349313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90245(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of LU90245A1 publication Critical patent/LU90245A1/fr
Application granted granted Critical
Publication of LU90245B1 publication Critical patent/LU90245B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU90245A 1997-05-29 1998-05-20 Pilules de fluox-tine ent-riques LU90245B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/867,196 US5910319A (en) 1997-05-29 1997-05-29 Fluoxetine enteric pellets and methods for their preparation and use

Publications (2)

Publication Number Publication Date
LU90245A1 true LU90245A1 (fr) 1998-11-30
LU90245B1 LU90245B1 (fr) 2002-07-31

Family

ID=25349313

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90245A LU90245B1 (fr) 1997-05-29 1998-05-20 Pilules de fluox-tine ent-riques

Country Status (46)

Country Link
US (3) US5910319A (fr)
JP (1) JP3210288B2 (fr)
KR (1) KR100549473B1 (fr)
CN (2) CN1161109C (fr)
AR (1) AR011728A1 (fr)
AT (1) AT408068B (fr)
AU (1) AU726690B2 (fr)
BE (1) BE1011925A3 (fr)
BR (1) BR9801989A (fr)
CA (1) CA2234826C (fr)
CH (1) CH693018A5 (fr)
CO (1) CO4940407A1 (fr)
CZ (1) CZ290582B6 (fr)
DE (1) DE19823940B4 (fr)
DK (1) DK176776B1 (fr)
ES (1) ES2161574B1 (fr)
FI (1) FI119971B (fr)
FR (1) FR2763846B1 (fr)
GB (1) GB2325623B (fr)
GR (1) GR980100188A (fr)
HK (1) HK1034902A1 (fr)
HU (1) HUP9800882A3 (fr)
ID (1) ID20343A (fr)
IL (1) IL124073A (fr)
IT (1) ITMI980908A1 (fr)
LT (1) LT4477B (fr)
LU (1) LU90245B1 (fr)
LV (1) LV12176B (fr)
MY (1) MY118139A (fr)
NL (1) NL1009259C2 (fr)
NO (1) NO317743B1 (fr)
NZ (1) NZ330192A (fr)
PE (1) PE75399A1 (fr)
PL (1) PL192293B1 (fr)
PT (1) PT102152B (fr)
RO (1) RO120043B1 (fr)
RS (1) RS49827B (fr)
RU (1) RU2164405C2 (fr)
SE (1) SE522914C2 (fr)
SG (1) SG72805A1 (fr)
SI (1) SI9800128B (fr)
SV (1) SV1998000052A (fr)
TR (1) TR199800937A2 (fr)
TW (1) TWI239838B (fr)
UA (1) UA48193C2 (fr)
ZA (1) ZA983173B (fr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
CA2698347A1 (fr) * 1999-05-20 2000-11-30 Elan Pharma International Limited Preparations d'inhibiteurs specifiques du recaptage de la serotonine a liberation multiparticulaire regulee
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
IL148159A0 (en) 1999-09-03 2002-09-12 Lilly Co Eli Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
CN1094347C (zh) * 1999-11-15 2002-11-20 广东药学院药物研究所 一种治疗前列腺良性增生症的控释微丸及其制备方法
US6273260B1 (en) 2000-03-08 2001-08-14 Eli Lilly And Company Pharmaceutical packaging system
ES2185452B2 (es) * 2000-08-01 2004-03-16 Cinfa S A Lab Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
JP4181738B2 (ja) * 2000-08-25 2008-11-19 信越化学工業株式会社 腸溶性コーティング製剤の製造方法
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
WO2002038126A2 (fr) * 2000-11-08 2002-05-16 Aeromatic-Fielder Ag Procede de production de particules pour preparations pharmaceutiques presentant une biodisponibilite accrue
WO2003013480A1 (fr) 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Preparation enterique de fluoxetine
US20040170688A1 (en) * 2001-08-06 2004-09-02 Deshmukh Abhijit Mukund Enteric formulation of fluoxetin
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004058228A1 (fr) * 2002-12-24 2004-07-15 Lupin Limited Composition de fluoxetine a enrobage enterique
US8614247B2 (en) * 2003-04-10 2013-12-24 Institut National De La Sante Et De La Recherche Medicale Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof
CA2753318A1 (fr) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Derives pyrroliques substitues
US20050176693A1 (en) * 2003-08-12 2005-08-11 Boissonneault Roger M. Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
JP2007517038A (ja) * 2003-12-30 2007-06-28 ドクター レディズ ラボラトリーズ リミテッド 薬学的組成物
EP1787640A4 (fr) * 2004-04-30 2012-04-11 Astellas Pharma Inc Composition pharmaceutique granulaire du type à libération limitée dans le temps en vue d'une administration orale et comprimé à désintégration rapide intra orale contenant la composition
KR100920856B1 (ko) * 2004-11-30 2009-10-09 (주)아모레퍼시픽 선택적 세로토닌 재흡수 억제제의 연장방출 제제 및 그제조방법
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
WO2007015270A2 (fr) * 2005-08-02 2007-02-08 Lupin Limited Nouvelles compositions a liberation controlee a base d'inhibiteurs selectifs de la recapture de la serotonine
SG166829A1 (en) 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
EP1951643A1 (fr) * 2005-11-23 2008-08-06 Auspex Pharmaceuticals Inc. Aryloxypropylamines substituées possédant une activité sérotoninergique et/ou norépinephrinergique
EP1863782A1 (fr) * 2005-12-05 2007-12-12 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphtol)thiophene, une impurete du duloxetine chlorhydrate
MX2008010879A (es) * 2006-02-24 2008-10-27 Teva Pharma Composiciones farmaceuticas de sodio de fluvastatina.
CN101057837B (zh) * 2006-04-20 2010-12-22 湖南九典制药有限公司 一种右旋酮洛芬肠溶微丸及制备方法
WO2007134168A2 (fr) * 2006-05-10 2007-11-22 Dr. Reddy's Laboratories Ltd. Procédé de préparation de duloxétine
RU2008148547A (ru) * 2006-05-22 2010-06-27 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические композиции, включающие дулоксетина гидрохлорид с замедленным высвобождением
CA2654402A1 (fr) * 2006-06-01 2007-12-06 Adel Penhasi Formulation pharmaceutique comprenant des unites multiples
JP5052051B2 (ja) * 2006-06-16 2012-10-17 トーアエイヨー株式会社 腸溶性顆粒剤及びその製造方法
US20090252787A1 (en) * 2006-07-28 2009-10-08 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US20090175935A1 (en) * 2006-08-14 2009-07-09 Torrent Research Ltd. Pharmaceutical compositions of duloxetine
CA2664421A1 (fr) * 2006-09-22 2008-03-27 Braincells, Inc. Modulation induite par hmg coa reductase de la neurogenese
US20080226711A1 (en) * 2007-03-12 2008-09-18 Torrent Pharmaceuticals Ltd. Pharmaceutical compositions of duloxetine
US20090226517A1 (en) * 2008-02-06 2009-09-10 Vinita Umashankar Vyas Pharmaceutical formulations comprising duloxetine
DK2317852T3 (en) 2008-07-16 2015-03-23 Richter Gedeon Nyrt PHARMACEUTICAL FORMULATIONS CONTAINING dopamine receptor ligands
WO2010026993A1 (fr) * 2008-09-03 2010-03-11 武田薬品工業株式会社 Procédé pour améliorer la capacité d'une préparation à être absorbée et préparation dont la capacité à être absorbée est améliorée
CN101804145B (zh) * 2009-02-12 2012-11-14 杭州赛利药物研究所有限公司 一种大蒜油肠溶微丸胶囊及其制备方法
WO2011039768A2 (fr) * 2009-09-17 2011-04-07 Cadila Healthcare Limited Compositions pharmaceutiques pour réduire une libération massive induite par l'alcool
TW201141544A (en) 2010-02-22 2011-12-01 Daiichi Sankyo Co Ltd Oral solid extended release dosage form
JP6397813B2 (ja) * 2012-05-02 2018-09-26 キャプシュゲル・ベルジウム・エヌ・ヴィ ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液
CN102716084B (zh) * 2012-06-29 2013-09-25 海南美大制药有限公司 盐酸氟西汀脂质体固体制剂
WO2014034929A1 (fr) 2012-09-03 2014-03-06 第一三共株式会社 Composition pharmaceutique à libération prolongée administrée par voie orale contenant du chlorhydrate d'hydromorphone
EP3610890A1 (fr) 2012-11-14 2020-02-19 The Johns Hopkins University Procédés et compositions de traitement de la schizophrénie
EP3145496B1 (fr) * 2014-05-20 2020-03-18 Dow Global Technologies LLC Enveloppes de capsule comprenant un éther de cellulose estérifié
EP3145498B1 (fr) * 2014-05-20 2020-03-04 Dow Global Technologies LLC Dispersion comportant un éther de cellulose estérifié partiellement neutralisé
US10564114B2 (en) * 2014-06-07 2020-02-18 Structure-Ase Incorporated Method for the detection and/or diagnosis of eating disorders and malnutrition using X-ray diffraction
US10471152B2 (en) 2014-08-29 2019-11-12 Capsugel Belgium Nv Colloidal dispersion comprising HPMCAS
EP3288556A4 (fr) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Compositions à désintégration par voie orale
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
MA52457A (fr) * 2017-04-13 2021-03-10 Chase Therapeutics Corp Combinaison pharmaceutique et son utilisation pour le traitement de synucléinopathies
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
CN107898942B (zh) * 2017-11-24 2021-01-26 一力制药(罗定)有限公司 一种感冒清热胶囊及其制备方法
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
WO2022115054A1 (fr) * 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Compositions de duloxétine à enrobage entérique

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0687472A2 (fr) * 1994-06-16 1995-12-20 Eli Lilly And Company Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
EP0693282A2 (fr) * 1994-07-18 1996-01-24 Eli Lilly And Company Pilules entériques contenant de la duloxétine

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4194009A (en) 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
JPS517116A (en) 1974-06-11 1976-01-21 Shinetsu Chemical Co Choyoseihifukuyakuzaino seizohoho
CH649216A5 (de) 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPS5855125B2 (ja) * 1980-03-10 1983-12-08 信越化学工業株式会社 固形薬剤用腸溶性コ−テイング剤組成物
US4444778A (en) * 1981-08-27 1984-04-24 Coughlin Shaun R Method and composition for treating atherosclerosis
US4797286A (en) 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4847092A (en) * 1985-11-12 1989-07-11 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US4918242A (en) 1988-03-30 1990-04-17 Aldrich Chemical Company, Inc. Novel optically 1,3-phenoxypropylhalides
CA1337955C (fr) * 1988-09-26 1996-01-23 Thomas A. Almquist Recouvrement de couches stereolithographiques
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5104899A (en) * 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
JPH04202124A (ja) * 1990-11-29 1992-07-22 Fuji Kagaku Kogyo Kk 噴霧乾燥造粒法による薬物放出の制御された製剤の製造法
WO1992013452A1 (fr) * 1991-02-04 1992-08-20 Young James W Procedes d'utilisation et compositions de r(-) fluoxetine
WO1992019241A1 (fr) * 1991-05-07 1992-11-12 Dynagen, Inc. Systeme d'administration a liberation prolongee regulee utilise pour cesser de fumer
WO1993018755A1 (fr) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Formes galeniques de medicament oral a liberation prolongee a base de cellulose a substitution alkyle
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
JPH06293633A (ja) * 1993-04-05 1994-10-21 Shin Etsu Chem Co Ltd 水性腸溶性エマルジョンの製造方法
US5362886A (en) 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
DE69426570T2 (de) * 1993-11-03 2001-08-23 Isomed Inc Mizelleförmige feinteilige pharmazeutische zusammensetzungen
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0687472A2 (fr) * 1994-06-16 1995-12-20 Eli Lilly And Company Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
EP0693282A2 (fr) * 1994-07-18 1996-01-24 Eli Lilly And Company Pilules entériques contenant de la duloxétine
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets

Also Published As

Publication number Publication date
US5985322A (en) 1999-11-16
FR2763846A1 (fr) 1998-12-04
JP3210288B2 (ja) 2001-09-17
FI119971B (fi) 2009-05-29
TR199800937A3 (tr) 1999-10-21
SG72805A1 (en) 2000-05-23
CH693018A5 (de) 2003-01-31
RO120043B1 (ro) 2005-08-30
AU6904898A (en) 1998-12-03
UA48193C2 (uk) 2002-08-15
HU9800882D0 (en) 1998-05-28
GR980100188A (el) 1999-01-29
YU16598A (en) 1999-11-22
BE1011925A3 (fr) 2000-03-07
PL192293B1 (pl) 2006-09-29
US5910319A (en) 1999-06-08
BR9801989A (pt) 2000-02-08
CA2234826A1 (fr) 1998-11-29
LV12176B (en) 1999-03-20
CO4940407A1 (es) 2000-07-24
CZ114398A3 (cs) 1998-12-16
NO982197D0 (no) 1998-05-14
JPH10330253A (ja) 1998-12-15
IE980284A1 (en) 2000-07-12
HUP9800882A3 (en) 2000-07-28
CA2234826C (fr) 2000-12-19
CN1161109C (zh) 2004-08-11
TWI239838B (en) 2005-09-21
PT102152A (pt) 1998-12-31
SE522914C2 (sv) 2004-03-16
GB9807939D0 (en) 1998-06-10
SE9801336D0 (sv) 1998-04-17
LT98058A (en) 1998-10-26
GB2325623A (en) 1998-12-02
DE19823940B4 (de) 2010-04-29
GB2325623B (en) 1999-04-14
HK1034902A1 (en) 2001-11-09
MY118139A (en) 2004-09-30
CN1212834C (zh) 2005-08-03
IL124073A (en) 2002-02-10
ES2161574A1 (es) 2001-12-01
CN1285189A (zh) 2001-02-28
ES2161574B1 (es) 2002-06-16
PL326134A1 (en) 1998-12-07
LT4477B (lt) 1999-03-25
PE75399A1 (es) 1999-08-17
LU90245B1 (fr) 2002-07-31
PT102152B (pt) 2000-09-29
FI980846A0 (fi) 1998-04-16
AT408068B (de) 2001-08-27
SE9801336L (sv) 1998-11-30
AR011728A1 (es) 2000-08-30
FI980846A (fi) 1998-11-30
NL1009259C2 (nl) 1998-12-01
KR100549473B1 (ko) 2006-03-23
ATA93198A (de) 2001-01-15
SV1998000052A (es) 1999-03-16
CN1200924A (zh) 1998-12-09
NO982197L (no) 1998-11-30
CZ290582B6 (cs) 2002-08-14
FR2763846B1 (fr) 2001-05-18
NZ330192A (en) 1999-08-30
NO317743B1 (no) 2004-12-13
RS49827B (sr) 2008-08-07
KR19980086622A (ko) 1998-12-05
SI9800128A (sl) 1999-02-28
ITMI980908A1 (it) 1999-10-28
DE19823940A1 (de) 1998-12-03
HUP9800882A2 (hu) 2000-03-28
ZA983173B (en) 1999-10-15
DK176776B1 (da) 2009-08-10
SI9800128B (sl) 2000-04-30
ID20343A (id) 1998-12-03
AU726690B2 (en) 2000-11-16
RU2164405C2 (ru) 2001-03-27
USRE39030E1 (en) 2006-03-21
TR199800937A2 (xx) 1999-10-21
LV12176A (lv) 1998-12-20

Similar Documents

Publication Publication Date Title
ITTO970512A0 (fr)
LU90245A1 (fr)
IN186343B (fr)
IN192099B (fr)
IN187300B (fr)
IN186125B (fr)
ITVR970046A0 (fr)
IN191392B (fr)
IN185769B (fr)
ITPN970021V0 (fr)
ITRM970123V0 (fr)
ITRM970288A0 (fr)
IN183483B (fr)
ITUD970096A0 (fr)
CN3058025S (fr)
CN3056419S (fr)
CN3057977S (fr)
CN3058000S (fr)
CN3058923S (fr)
CN3057730S (fr)
CN3058057S (fr)
CN3058088S (fr)
CN3054162S (fr)
CN3057614S (fr)
CN3057613S (fr)